🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In 2018 the Unity MR-linac was approved for treating patients with online m...
Status
Completed
Location
Odense University Hospital
Start Date
2020-11-19
Trial ID
NCT05615909
Treatments Being Tested
This Phase II study is to determine the efficacy and safety of MR-Linac Gui...
Status
Unknown
Location
Hui Liu
Start Date
2021-10-01
Trial ID
NCT05163509
Treatments Being Tested
Glioblastoma (GBM) is a high grade glioma (brain tumor) that is treated wit...
Status
Completed
Location
Sunnybrook Health Sciences Centre
Start Date
2021-03-29
Trial ID
NCT04726397
Treatments Being Tested
This study builds on the results of prior studies (UNITED and UNITED-3). Th...
Status
Recruiting
Location
Sunnybrook Health Sciences Centre - Odette Cancer Centre
Start Date
2025-09-10
Trial ID
NCT07459101
Treatments Being Tested
The purpose of this study is to assess the impact of prostate-specific memb...
Status
Recruiting
Location
NYU Langone Health
Start Date
2025-08-15
Trial ID
NCT07142967
Treatments Being Tested
The goal of this study is to test whether an adaptive radiation therapy (RT...
Status
Active Not Recruiting
Location
Sunnybrook Health Sciences Centre
Start Date
2023-04-01
Trial ID
NCT05720078
Treatments Being Tested
This is a multicenter, randomized, controlled phase III trial to evaluate t...
Status
Suspended
Location
Department of Radiation Oncology, Shandong Cancer Hospital and Institute
Start Date
2023-12-01
Trial ID
NCT06246344
The purpose of this study is to assess the impact of this MR-guided radioth...
Status
Recruiting
Location
NYU Langone Health
Start Date
2024-12-09
Trial ID
NCT06542757
Treatments Being Tested
This Phase II study is to determine the efficacy and safety of MR-Linac Gui...
Status
Completed
Location
Hui Liu
Start Date
2021-06-01
Trial ID
NCT04946019
Treatments Being Tested